Article

cambridgeindependent.co.uk on 2017-09-13 23:11

Bicycle Therapeutics deal for haemophilia and sickle cell disease therapies could be worth $410million

The biotech firm based on Babraham Research Campus is working with life sciences company Bioverativ Inc.

Massachusetts

Related news

MGlobal Blood Therapeutics and Syros Pharmaceuticals partner for sickle cell therapies marketwatch.com
IBicycle Therapeutics reports promising BT8009 study results, shares tank 30%invezz.com
New Orleans , Phase 1
Cancer Research UK to fund clinical trial of Bicycle Therapeutics immuno-oncology candidate cambridgeindependent.co.uk
Two gene therapies for sickle cell disease approved in US Seattle Times
Bahrain , United Kingdom , Africa
Two gene therapies for sickle cell disease approved in U.S.staradvertiser.com
New Orleans , Bahrain , United Kingdom , Kentucky , Louisville
2 gene therapies for sickle cell disease approved in US Alaska Dispatch News
New Orleans , Bahrain , United Kingdom , Kentucky , Africa
Penn spinout Verismo Therapeutics raises $16M to advance cell therapies bizjournals.com
IFast-tracking T cell therapies with immune-mimicking biomaterials innovations-report.com
Massachusetts , Cambridge
FDA approves first cell-based gene therapies for sickle cell disease newatlas.com
Fast Track
NFDA Approves Groundbreaking Cell-Based Gene Therapies for Sickle Cell Disease nnpa.org
Fast Track , United States
FDA Approves First Cell-Based Therapies for Treatment of Sickle Cell Disease jdsupra.com
Bahrain , Great Britain
Will Sickle Cell Be the Next Disease Genetic Engineering Cures?gizmodo.com
Cincinnati , Massachusetts , France , Cures
Sickle-cell patients dreamed of a cure; enter gene therapy The New York Times
South Carolina , Charleston , Massachusetts , Cambridge , Africa
TGene-editing treatment shows promise for sickle cell disease twincities.com
Milwaukee , Massachusetts , Cambridge , Switzerland , United States